Koyfin Home > Directory > Health Care > Acceleron Pharma > Price / Sales (ntm)

Acceleron Pharma Price / Sales (ntm) Chart (XLRN)

Acceleron Pharma annual/quarterly Price / Sales (ntm) from 2013 to 2020.
  • Acceleron Pharma Price / Sales (ntm) for the quarter ending October 10, 2020 was 53.11 a 0.46% increase of 0.25 year over year
  • Acceleron Pharma Price / Sales (ntm) for the last 12 months ending October 10, 2020 was 53.11 a 0.46% increase of 0.25 year over year
  • Acceleron Pharma Annual Price / Sales (ntm) for 2020 was 53.11 a -0.04% decrease of -0.02 from 2019
  • Acceleron Pharma Annual Price / Sales (ntm) for 2020 was 53.13 a 3.96% increase of 2.10 from 2019
  • Acceleron Pharma Annual Price / Sales (ntm) for 2020 was 51.02 a -3.60% decrease of -1.84 from 2019
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN Price / Sales (ntm) Data

10/202053.11
10/202053.13
10/202051.02
10/202052.86
10/202054.34
10/202055.10
10/202055.06
10/202055.56
10/202057.63
10/202056.20

Annual XLRN Price / Sales (ntm) Data

202053.11
202053.13
202051.02
202052.86
202054.34
202055.10
202055.06
202055.56
202057.63
202056.20